Arrivent Biopharma, Inc. · NASDAQ:AVBP
Hillhouse Investment Management, Ltd. reported a 9.50% stake in Arrivent Biopharma, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Hillhouse Investment Management, Ltd. reported a 9.50% stake in Arrivent Biopharma, Inc., 3,929,117 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.50%
- Shares
- 3,929,117
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Hillhouse Investment Management, Ltd. | 9.50% | 3,929,117 |
Source
Related
- Arrivent Biopharma, Inc.
- Hillhouse Investment Management, Ltd.
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026